Literature DB >> 23481164

Multiparametric prostate MR imaging with T2-weighted, diffusion-weighted, and dynamic contrast-enhanced sequences: are all pulse sequences necessary to detect locally recurrent prostate cancer after radiation therapy?

Olivio F Donati1, Sung Il Jung, Hebert Alberto Vargas, David H Gultekin, Junting Zheng, Chaya S Moskowitz, Hedvig Hricak, Michael J Zelefsky, Oguz Akin.   

Abstract

PURPOSE: To compare diagnostic accuracy of T2-weighted magnetic resonance (MR) imaging with that of multiparametric (MP) MR imaging combining T2-weighted imaging with diffusion-weighted (DW) MR imaging, dynamic contrast material-enhanced (DCE) MR imaging, or both in the detection of locally recurrent prostate cancer (PCa) after radiation therapy (RT).
MATERIALS AND METHODS: This retrospective HIPAA-compliant study was approved by the institutional review board; informed consent was waived. Fifty-three men (median age, 70 years) suspected of having post-RT recurrence of PCa underwent MP MR imaging, including DW and DCE sequences, within 6 months after biopsy. Two readers independently evaluated the likelihood of PCa with a five-point scale for T2-weighted imaging alone, T2-weighted imaging with DW imaging, T2-weighted imaging with DCE imaging, and T2-weighted imaging with DW and DCE imaging, with at least a 4-week interval between evaluations. Areas under the receiver operating characteristic curve (AUC) were calculated. Interreader agreement was assessed, and quantitative parameters (apparent diffusion coefficient [ADC], volume transfer constant [K(trans)], and rate constant [k(ep)]) were assessed at sextant- and patient-based levels with generalized estimating equations and the Wilcoxon rank sum test, respectively.
RESULTS: At biopsy, recurrence was present in 35 (66%) of 53 patients. In detection of recurrent PCa, T2-weighted imaging with DW imaging yielded higher AUCs (reader 1, 0.79-0.86; reader 2, 0.75-0.81) than T2-weighted imaging alone (reader 1, 0.63-0.67; reader 2, 0.46-0.49 [P ≤ .014 for all]). DCE sequences did not contribute significant incremental value to T2-weighted imaging with DW imaging (reader 1, P > .99; reader 2, P = .35). Interreader agreement was higher for combinations of MP MR imaging than for T2-weighted imaging alone (κ = 0.34-0.63 vs κ = 0.17-0.20). Medians of quantitative parameters differed significantly (P < .0001 to P = .0233) between benign tissue and PCa (ADC, 1.64 × 10(-3) mm(2)/sec vs 1.13 × 10(-3) mm(2)/sec; K(trans), 0.16 min(-1) vs 0.33 min(-1); k(ep), 0.36 min(-1) vs 0.62 min(-1)).
CONCLUSION: MP MR imaging has greater accuracy in the detection of recurrent PCa after RT than T2-weighted imaging alone, with no additional benefit if DCE is added to T2-weighted imaging and DW imaging.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23481164      PMCID: PMC6940013          DOI: 10.1148/radiol.13122149

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  35 in total

1.  Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies.

Authors:  C S Stewart; B C Leibovich; A L Weaver; M M Lieber
Journal:  J Urol       Date:  2001-07       Impact factor: 7.450

2.  Nonparametric analysis of clustered ROC curve data.

Authors:  N A Obuchowski
Journal:  Biometrics       Date:  1997-06       Impact factor: 2.571

3.  Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis.

Authors:  Aytekin Oto; Cheng Yang; Arda Kayhan; Maria Tretiakova; Tatjana Antic; Christine Schmid-Tannwald; Scott Eggener; Gregory S Karczmar; Walter M Stadler
Journal:  AJR Am J Roentgenol       Date:  2011-12       Impact factor: 3.959

4.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

Review 5.  MR imaging of treated prostate cancer.

Authors:  Hebert Alberto Vargas; Cecilia Wassberg; Oguz Akin; Hedvig Hricak
Journal:  Radiology       Date:  2012-01       Impact factor: 11.105

6.  Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology.

Authors:  A E Wefer; H Hricak; D B Vigneron; F V Coakley; Y Lu; J Wefer; U Mueller-Lisse; P R Carroll; J Kurhanewicz
Journal:  J Urol       Date:  2000-08       Impact factor: 7.450

7.  Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness.

Authors:  Hebert Alberto Vargas; Oguz Akin; Tobias Franiel; Yousef Mazaheri; Junting Zheng; Chaya Moskowitz; Kazuma Udo; James Eastham; Hedvig Hricak
Journal:  Radiology       Date:  2011-03-24       Impact factor: 11.105

Review 8.  Gleason grading and prognostic factors in carcinoma of the prostate.

Authors:  Peter A Humphrey
Journal:  Mod Pathol       Date:  2004-03       Impact factor: 7.842

9.  Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

Authors:  A V D'Amico; R Whittington; S B Malkowicz; D Schultz; K Blank; G A Broderick; J E Tomaszewski; A A Renshaw; I Kaplan; C J Beard; A Wein
Journal:  JAMA       Date:  1998-09-16       Impact factor: 56.272

Review 10.  Management of prostate cancer recurrence after definitive radiation therapy.

Authors:  Christian Boukaram; Jean-Michel Hannoun-Levi
Journal:  Cancer Treat Rev       Date:  2010-01-25       Impact factor: 12.111

View more
  45 in total

1.  The value of multimodality imaging in the investigation of a PSA recurrence after radical prostatectomy in the Irish hospital setting.

Authors:  L C McLoughlin; S Inder; D Moran; C O'Rourke; R P Manecksha; T H Lynch
Journal:  Ir J Med Sci       Date:  2017-06-13       Impact factor: 1.568

2.  Restriction spectrum imaging improves MRI-based prostate cancer detection.

Authors:  Kevin C McCammack; Natalie M Schenker-Ahmed; Nathan S White; Shaun R Best; Robert M Marks; Jared Heimbigner; Christopher J Kane; J Kellogg Parsons; Joshua M Kuperman; Hauke Bartsch; Rahul S Desikan; Rebecca A Rakow-Penner; Michael A Liss; Daniel J A Margolis; Steven S Raman; Ahmed Shabaik; Anders M Dale; David S Karow
Journal:  Abdom Radiol (NY)       Date:  2016-05

3.  A Domain Constrained Deformable (DoCD) Model for Co-registration of Pre- and Post-Radiated Prostate MRI.

Authors:  Robert Toth; Bryan Traughber; Rodney Ellis; John Kurhanewicz; Anant Madabhushi
Journal:  Neurocomputing       Date:  2014-11-20       Impact factor: 5.719

4.  Effect of color visualization and display hardware on the visual assessment of pseudocolor medical images.

Authors:  Silvina Zabala-Travers; Mina Choi; Wei-Chung Cheng; Aldo Badano
Journal:  Med Phys       Date:  2015-06       Impact factor: 4.071

5.  Multiparametric MRI for detection of radiorecurrent prostate cancer: added value of apparent diffusion coefficient maps and dynamic contrast-enhanced images.

Authors:  M Abd-Alazeez; N Ramachandran; N Dikaios; H U Ahmed; M Emberton; A Kirkham; M Arya; S Taylor; S Halligan; S Punwani
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-02-03       Impact factor: 5.554

Review 6.  The role of MRI for detection and staging of radio- and focal therapy-recurrent prostate cancer.

Authors:  Henk van der Poel; Nikos Grivas; Pim van Leeuwen; Stijn Heijmink; Ivo Schoots
Journal:  World J Urol       Date:  2019-02-20       Impact factor: 4.226

7.  Multiparametric 3T MRI for the prediction of pathological downgrading after radical prostatectomy in patients with biopsy-proven Gleason score 3 + 4 prostate cancer.

Authors:  Tatsuo Gondo; Hedvig Hricak; Evis Sala; Junting Zheng; Chaya S Moskowitz; Melanie Bernstein; James A Eastham; Hebert Alberto Vargas
Journal:  Eur Radiol       Date:  2014-08-07       Impact factor: 5.315

Review 8.  Restriction spectrum imaging: An evolving imaging biomarker in prostate MRI.

Authors:  Ryan L Brunsing; Natalie M Schenker-Ahmed; Nathan S White; J Kellogg Parsons; Christopher Kane; Joshua Kuperman; Hauke Bartsch; Andrew Karim Kader; Rebecca Rakow-Penner; Tyler M Seibert; Daniel Margolis; Steven S Raman; Carrie R McDonald; Nikdokht Farid; Santosh Kesari; Donna Hansel; Ahmed Shabaik; Anders M Dale; David S Karow
Journal:  J Magn Reson Imaging       Date:  2016-08-16       Impact factor: 4.813

Review 9.  Clinical applications for diffusion magnetic resonance imaging in radiotherapy.

Authors:  Christina Tsien; Yue Cao; Thomas Chenevert
Journal:  Semin Radiat Oncol       Date:  2014-07       Impact factor: 5.934

Review 10.  Functional MR Imaging Techniques in Oncology in the Era of Personalized Medicine.

Authors:  Matthias R Benz; Hebert Alberto Vargas; Evis Sala
Journal:  Magn Reson Imaging Clin N Am       Date:  2015-09-26       Impact factor: 2.266

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.